Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

115
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
115
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

19.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K
Experimental RNAi02:15

Experimental RNAi

8.4K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.4K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

113
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
113
RNA Interference01:23

RNA Interference

28.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.7K
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

124
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
124

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The AudioScatter Package in RStudio to Generate Scattergrams for Reporting Hearing Results.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2025
Same author

Optical coherence tomography-based cochlear endoscopy through the human round window membrane.

Optics letters·2025
Same author

Optical coherence tomography imaging demonstrates endolymphatic hydrops in the lateral and posterior semicircular canals in noise-exposed mice.

Hearing research·2025
Same author

Human inner ear fluid imbalance detected by optical coherence tomography correlates with hearing loss.

Science translational medicine·2025
Same author

Facial Nerve Amyloidosis Leading to Unilateral Facial Paralysis and Sensorineural Hearing Loss.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2025
Same author

Imaging the <i>ex-vivo</i> human cochlea using 1.3-<i>μ</i>m and 1.7-<i>μ</i>m optical coherence tomography.

Journal of biomedical optics·2025

Related Experiment Video

Updated: Apr 7, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

8.1K

Cationic Mucic Acid Polymer-Based siRNA Delivery Systems.

Dorothy W Pan1, Mark E Davis1

  • 1Chemical Engineering, California Institute of Technology, Pasadena, California 91125, United States.

Bioconjugate Chemistry
|July 9, 2015
PubMed
Summary
This summary is machine-generated.

Novel cationic mucic acid polymers form stable nanoparticle (NP) systems for small interfering RNA (siRNA) delivery. The mPEG-cMAP-PEGm triblock polymer formulation demonstrated the longest systemic circulation time for siRNA-loaded NPs.

More Related Videos

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

11.6K
Assembly and Characterization of Polyelectrolyte Complex Micelles
08:44

Assembly and Characterization of Polyelectrolyte Complex Micelles

Published on: March 2, 2020

11.7K

Related Experiment Videos

Last Updated: Apr 7, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

8.1K
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

11.6K
Assembly and Characterization of Polyelectrolyte Complex Micelles
08:44

Assembly and Characterization of Polyelectrolyte Complex Micelles

Published on: March 2, 2020

11.7K

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Nanotechnology

Background:

  • Developing effective nanoparticle (NP) delivery systems for small interfering RNA (siRNA) is crucial for clinical translation.
  • Existing systems often struggle with adequate systemic circulation and high nucleic acid loading.

Purpose of the Study:

  • To synthesize and characterize novel cationic mucic acid-containing polymers for siRNA NP formulation.
  • To evaluate the systemic circulation and stability of siRNA-loaded NPs using different polymer architectures.

Main Methods:

  • Synthesis of cationic mucic acid polymer (cMAP) and its conjugation with poly(ethylene glycol) (PEG) via copolymer and triblock architectures.
  • Formation of siRNA-loaded NPs using various cMAP-PEG formulations.
  • Evaluation of NP size, stability, and in vivo circulation time in mice.

Main Results:

  • Five distinct NP formulations were created, ranging from 30-40 nm in size.
  • The mPEG-cMAP-PEGm triblock polymer formulation exhibited the longest circulation time in mice.
  • This triblock formulation, even when purified, could achieve up to 30 wt % siRNA loading.

Conclusions:

  • Cationic mucic acid-containing polymers are effective for forming stable siRNA-loaded NPs.
  • The mPEG-cMAP-PEGm triblock polymer offers superior in vivo circulation for siRNA delivery applications.
  • These findings support the potential of these novel NPs for clinical translation.